Clinical Trials

Showing trials with last updates posted in 2025.

NCT04024436 | TERMINATED | PHASE2
64 Participants

A Study of TAS-120 in Patients With Metastatic Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2020-01-28
Completion: 2023-05-31
Conditions
Metastatic Breast Cancer FGFR 1 High Amplification FGFR2 Amplification
Interventions
DRUG
NCT03978442 | COMPLETED | PHASE4
120 Participants

CPT-SMART for Treatment of PTSD and Cigarette Smoking

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-11-07
Completion: 2025-10-08
Conditions
Smoking Stress Disorders, Post-Traumatic
Interventions
BEHAVIORAL DRUG
No Results Yet
NCT03937635 | RECRUITING | PHASE3
288 Participants

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-09-16
Completion: 2029-12-31
Conditions
Smoldering Plasma Cell Myeloma
Interventions
BIOLOGICAL DRUG OTHER
No Results Yet
NCT03935750 | ACTIVE_NOT_RECRUITING | NA
1236 Participants

STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2020-07-28
Completion: 2026-02-28
Conditions
Anterior Cruciate Ligament Injury Anterior Cruciate Ligament Reconstruction Joint Instability
Interventions
PROCEDURE
No Results Yet
NCT03901963 | ACTIVE_NOT_RECRUITING | PHASE3
200 Participants
NCT03899155 | RECRUITING | PHASE2
1500 Participants

Pan Tumor Rollover Study

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-08-09
Completion: 2029-08-25
Conditions
Cancer
Interventions
DRUG
No Results Yet
NCT03818763 | ACTIVE_NOT_RECRUITING | PHASE1
5 Participants

Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2020-04-29
Completion: 2026-03-31
Conditions
Hemophilia A
Interventions
BIOLOGICAL
No Results Yet
NCT03804255 | WITHDRAWN
0 Participants

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Study Type: OBSERVATIONAL
Last Updated: 2025-11-13
Start Date: 2019-01-08
Completion: 2020-05-29
Conditions
Breast Carcinoma Colorectal Carcinoma Community Practice Lung Carcinoma Melanoma Solid Neoplasm
Interventions
OTHER
No Results Yet
NCT03797183 | RECRUITING
90 Participants

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

Study Type: OBSERVATIONAL
Last Updated: 2025-11-13
Start Date: 2019-05-03
Completion: 2026-11-30
Conditions
Premature Infant Chronic Respiratory Disease Neuromuscular Diseases Healthy Bronchopulmonary Dysplasia Pulmonary Vein Stenoses
No Results Yet
NCT03787290 | SUSPENDED | PHASE2
35 Participants

Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2026-12-01
Completion: 2028-12-01
Conditions
Major Depressive Disorder
Interventions
DRUG DEVICE
No Results Yet
NCT03750513 | RECRUITING | PHASE1
48 Participants

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-04-01
Completion: 2027-12-31
Conditions
Anaplastic Ependymoma Ependymoma
Interventions
RADIATION OTHER
No Results Yet
NCT03748641 | ACTIVE_NOT_RECRUITING | PHASE3
765 Participants

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-01-25
Completion: 2021-10-08
Conditions
Castration-Resistant Prostatic Cancer
Interventions
DRUG
NCT03718325 | TERMINATED | NA
12 Participants

Burst Spinal Cord Stimulation (Burst-SCS) Study

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-03-12
Completion: 2020-03-10
Conditions
Pain, Chronic Failed Back Surgery Syndrome
Interventions
DEVICE
NCT03706430 | TERMINATED
63 Participants

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-09-24
Completion: 2021-10-20
Conditions
Surgery Anesthesia
Interventions
DEVICE
NCT03697148 | ACTIVE_NOT_RECRUITING | NA
852 Participants

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-02-11
Completion: 2025-12-31
Conditions
Prostate Carcinoma
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT03674138 | COMPLETED | NA
99 Participants

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-09-12
Completion: 2021-09-03
Conditions
Depression Anxiety Generalized Anxiety Disorder Depressive Disorder Major Depressive Disorder Cancer
Interventions
DIAGNOSTIC_TEST OTHER
No Results Yet
NCT03670355 | COMPLETED | PHASE1
49 Participants

Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-01-02
Completion: 2019-09-25
Conditions
HIV Infections
Interventions
DRUG
NCT03633708 | RECRUITING | PHASE3
56 Participants

A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-04-29
Completion: 2029-01-31
Conditions
Secondary Hyperparathyroidism Chronic Kidney Disease
Interventions
DRUG
No Results Yet
NCT03623958 | RECRUITING | NA
200 Participants

Image Guided VATS vs. VATS Resection

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-09-11
Completion: 2027-07-31
Conditions
Lung Cancer
Interventions
DEVICE PROCEDURE
No Results Yet
NCT03581292 | ACTIVE_NOT_RECRUITING | PHASE2
38 Participants

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-11-06
Completion: 2023-03-31
Conditions
Anaplastic Astrocytoma Glioblastoma Malignant Glioma
Interventions
RADIATION DRUG
NCT03550391 | RECRUITING | PHASE3
206 Participants

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-11-22
Completion: 2027-06-30
Conditions
Brain Metastases
Interventions
DRUG RADIATION PROCEDURE
No Results Yet
NCT03525951 | COMPLETED | NA
156 Participants

Parent-Level Predictors of Early Language Interaction Quality and Intervention Outcomes

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2021-03-22
Completion: 2025-09-18
Conditions
Language Development Disorders Autism Spectrum Disorder
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT03517436 | ACTIVE_NOT_RECRUITING | NA
101 Participants

ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-09-18
Completion: 2020-10-02
Conditions
Aortic Valve Stenosis
Interventions
DEVICE
NCT03516279 | ACTIVE_NOT_RECRUITING | PHASE2
40 Participants

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-06-26
Completion: 2028-08-31
Conditions
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Minimal Residual Disease
Interventions
DRUG OTHER BIOLOGICAL
No Results Yet
NCT03504644 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
74 Participants

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-08-03
Completion: 2025-12-31
Conditions
Recurrent Adult Lymphoblastic Lymphoma Recurrent B Acute Lymphoblastic Leukemia Recurrent B Lymphoblastic Lymphoma Recurrent T Acute Lymphoblastic Leukemia Recurrent T Lymphoblastic Lymphoma Refractory B Acute Lymphoblastic Leukemia Refractory B Lymphoblastic Lymphoma Refractory T Acute Lymphoblastic Leukemia Refractory T Lymphoblastic Lymphoma
Interventions
PROCEDURE DRUG
No Results Yet
NCT03493425 | RECRUITING | PHASE2
82 Participants

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2019-03-12
Completion: 2029-03-31
Conditions
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
Interventions
DRUG RADIATION OTHER PROCEDURE
No Results Yet
NCT03488693 | RECRUITING | PHASE3
2140 Participants

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-10-16
Completion: 2027-09-01
Conditions
Breast Cancer
Interventions
RADIATION OTHER
No Results Yet
NCT03462719 | ACTIVE_NOT_RECRUITING | PHASE3
211 Participants

A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-04-17
Completion: 2021-02-26
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
Interventions
DRUG
NCT03451851 | ACTIVE_NOT_RECRUITING | PHASE3
120 Participants

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-07-11
Completion: 2023-07-19
Conditions
Psoriasis
Interventions
DRUG
NCT03429907 | ACTIVE_NOT_RECRUITING | NA
62 Participants

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2017-12-05
Completion: 2026-04-30
Conditions
Malignant Neoplasm of Breast
Interventions
BEHAVIORAL
No Results Yet
NCT03419234 | ACTIVE_NOT_RECRUITING | PHASE2
223 Participants

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-04-26
Completion: 2026-03-31
Conditions
Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Adenocarcinoma AJCC v7
Interventions
DRUG OTHER PROCEDURE
No Results Yet
NCT03390504 | ACTIVE_NOT_RECRUITING | PHASE3
629 Participants

A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-03-23
Completion: 2024-04-15
Conditions
Urothelial Cancer
Interventions
DRUG DEVICE
NCT03375307 | RECRUITING | PHASE2
150 Participants

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2020-11-03
Completion: 2025-12-16
Conditions
Advanced Bladder Carcinoma Advanced Genitourinary System Carcinoma Metastatic Bladder Carcinoma Metastatic Genitourinary System Carcinoma Stage III Bladder Cancer AJCC v8 Stage IV Bladder Cancer AJCC v8
Interventions
PROCEDURE DRUG
No Results Yet
NCT03309332 | ACTIVE_NOT_RECRUITING | NA
1214 Participants

AMPLATZER PFO Occluder Post Approval Study

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-01-31
Completion: 2030-02-05
Conditions
Stroke Patent Foramen Ovale
Interventions
DEVICE
No Results Yet
NCT03267433 | ACTIVE_NOT_RECRUITING | PHASE3
689 Participants

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2017-11-27
Completion: 2027-01-31
Conditions
Mantle Cell Lymphoma
Interventions
PROCEDURE BIOLOGICAL
No Results Yet
NCT03233191 | ACTIVE_NOT_RECRUITING | PHASE3
108508 Participants

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2017-09-28
Completion: 2028-12-31
Conditions
Breast Screening
Interventions
PROCEDURE OTHER
No Results Yet
NCT03115333 | ACTIVE_NOT_RECRUITING | NA
146 Participants

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2017-07-25
Completion: 2025-12-31
Conditions
Gliosarcoma Recurrent Glioblastoma
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT03107780 | TERMINATED | PHASE1
32 Participants

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2018-07-09
Completion: 2025-08-15
Conditions
Glioblastoma Gliosarcoma MGMT-Unmethylated Glioblastoma Recurrent Glioblastoma
Interventions
PROCEDURE DRUG RADIATION
No Results Yet
NCT02998229 | RECRUITING | NA
220 Participants

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2024-04-16
Completion: 2027-08-31
Conditions
Intracranial Aneurysm
Interventions
DEVICE
No Results Yet
NCT02959463 | ACTIVE_NOT_RECRUITING | PHASE1
24 Participants

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-13
Start Date: 2017-05-01
Completion: 2024-11-15
Conditions
Pleural Malignant Mesothelioma
Interventions
OTHER RADIATION BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page · Total 107903 trials